Corynebacterium jeikeium sepsis after 8-methoxypsolaren photopheresis for cutaneous T-cell lymphoma.
We describe a patient with cutaneous T-cell lymphoma who developed Corynebacterium jeikeium sepsis after experimental treatment with 8-methoxypsolaren. The epidemiology and clinical features of C. jeikeium infection are discussed. The patient was successfully treated with intravenous vancomycin without recurrence.
Umeh
Obiamiwe Chukwudiebere
OC
Division of Infectious Diseases, Department of Medicine, UCLA Medical Center, Los Angeles, CA, USA. oumeh@mednet.ucla.edu
Kubak
Bernard Michael
BM
Pegues
David Alexander
DA
Leibowitz
Matthew Richard
MR
Froch
Larry
L
D000368:Aged; D016470:Bacteremia / Q000175:diagnosis* / Q000188:drug therapy / Q000276:immunology; D003352:Corynebacterium / Q000145:classification; D003354:Corynebacterium Infections / Q000175:diagnosis* / Q000188:drug therapy / Q000276:immunology; D005500:Follow-Up Studies; D006801:Humans; D016867:Immunocompromised Host; D007262:Infusions, Intravenous; D016410:Lymphoma, T-Cell, Cutaneous / Q000276:immunology* / Q000628:therapy; D008297:Male; D008730:Methoxsalen / Q000627:therapeutic use; D009894:Opportunistic Infections / Q000188:drug therapy / Q000276:immunology / Q000382:microbiology*; D017893:Photopheresis / Q000379:methods*; D018570:Risk Assessment; D012720:Severity of Illness Index; D016896:Treatment Outcome; D014640:Vancomycin / Q000008:administration & dosage
D014640:Vancomycin; D008730:Methoxsalen